Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study

OBJECTIVE: Infection is a major cause of death in patients with SLE. This study aimed to explore the infection rate in patients with SLE receiving a low dose of intravenous cyclophosphamide (IV-CYC). METHODS: Clinical parameters of 1022 patients with SLE from 24 hospitals in China were collected. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Miao, Miao, Miao, Zhang, Xia, Zhang, Xiaoying, An, Yuan, Guo, Huifang, Lei, Lingyan, Zhao, Qing, Ding, Yanjie, Lin, Jin, Wu, Rui, Yu, Feng, Li, Yucui, Miao, Huali, Zhang, Liyun, Du, Yan, Jiao, Ruiying, Pang, Lixia, Long, Li, Yao, Xueming, Shi, Xiaofei, Wang, Fei, Cui, Luping, Zhang, Lei, Liu, Shengyun, Lu, Fuai, Luo, Kangkai, Zhao, Simeng, Wang, Yongfu, Wu, Xiao, Wang, Qingwen, Liu, Hongjiang, Song, Shulin, Zhou, Xiaoyuan, Zhang, Xiaoping, Shi, Shumei, Zhu, Hong, Chen, Yao, Yu, Honglian, Wu, Jie, Yu, Ruiyun, Fan, Wenqiang, Liu, Shuang, Xu, Jian, Chen, Zhibin, Shi, Lianjie, He, Jing, Zhang, Xuewu, Li, Zhanguo, Li, Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644361/
https://www.ncbi.nlm.nih.gov/pubmed/36351697
http://dx.doi.org/10.1136/lupus-2022-000779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644361/
https://www.ncbi.nlm.nih.gov/pubmed/36351697
http://dx.doi.org/10.1136/lupus-2022-000779

Ejemplares similares